| 12/13/2024 | BKCVHY | S&P upgrades Jazz
|
| 12/11/2024 | BKCVHY | Moody’s lifts Jazz Pharmaceuticals
|
| 11/26/2024 | BK | Jazz Pharmaceuticals lifts revolver to $885 million, extends to 2029
|
| 9/4/2024 | BKCVHY | Fitch rates Jazz notes BB
|
| 6/13/2024 | BK | Jazz Pharmaceuticals launches $2.72 billion loan at SOFR plus 225 bps
|
| 6/13/2024 | BKCVHY | S&P assigns BB- to Jazz Financing Lux loan
|
| 3/28/2024 | BKCVHY | Fitch raises Jazz
|
| 1/25/2024 | BKCVHY | Moody’s upgrades Jazz Pharmaceuticals
|
| 1/8/2024 | BK | Market Commentary: Zelis, Clarios tweak deals; Inspire, Citadel, Caliber, Jane, DirecTV and more set talk
|
| 7/5/2023 | BKCVHY | S&P moves Jazz outlook to positive
|
| 1/20/2023 | BKCVHY | Moody's views Jazz Pharma positively
|
| 5/13/2022 | BKCVHY | Fitch revises Jazz outlook to positive
|
| 4/11/2022 | BKCVHY | Moody's turns Jazz Pharma view to stable
|
| 5/5/2021 | BKCVHY | S&P cuts Jazz Pharmaceuticals
|
| 4/23/2021 | BKCVDDEMIGPV | Market Commentary: Triple-hook deals in Friday junk primary; Jazz, Imperial Dade at a premium; goeasy gains
|
| 4/22/2021 | BK | Market Commentary: Jazz, Wells Fargo, Signature, FleetCor, Parts Authority break; Resonetics changes emerge
|
| 4/22/2021 | BK | Jazz Pharmaceuticals lifts term loan B to $3.85 billion equivalent
|
| 4/21/2021 | BKCVHY | S&P rates Jazz notes BB-
|
| 4/20/2021 | BKCVDDEMIGPV | Market Commentary: High yield: Morgan Automotive prices; Jazz megadeal on tap; Charter flat; Emergent down again
|
| 4/20/2021 | BKCVHY | Fitch rates Jazz notes BB+
|
| 4/20/2021 | BKCVHY | Moody's assigns Jazz Pharma notes Ba2
|
| 4/12/2021 | BK | Market Commentary: ArcLight NGPL breaks; Jazz, United Airlines, UPC, GMS, Cision release price guidance
|
| 4/12/2021 | BK | Jazz Pharmaceuticals reveals talk on $2.65 billion equivalent term B
|
| 4/9/2021 | BKCVHY | Fitch assigns Jazz Pharmaceuticals BB-
|
| 4/9/2021 | BK | Market Commentary: Hunter Fan, Aecom, Frontier Communications, TI Group free to trade; Aptean releases talk
|
| 4/9/2021 | BKCVHY | Moody's gives Jazz Pharma facilities Ba2
|
| 4/9/2021 | BK | Jazz Pharmaceuticals to launch $2.65 billion equivalent term B Monday
|
| 4/9/2021 | BKCVHY | S&P rates Jazz loan BB-
|
| 2/4/2021 | BKCV | S&P puts Jazz Pharmaceuticals on watch
|
| 2/4/2021 | BKHY | Jazz Pharmaceuticals gets $5.85 billion debt commitment for GW buy
|
| 2/4/2021 | BKCV | Moody’s reviews Jazz for downgrade
|
| 2/3/2021 | BK | Jazz Pharmaceuticals plans new debt financing for GW purchase
|
| 6/7/2018 | BK | Jazz Pharmaceuticals expands revolver, adds term loan
|
| 8/18/2017 | BKCV | Moody’s upgrades Jazz debt
|
| 8/17/2017 | BK | Jazz Pharmaceuticals to repay revolver borrowings via note offering
|
| 4/11/2017 | BK | Moody’s revises Jazz Securities to stable
|
| 6/1/2016 | BKCV | Moody’s lowers Jazz to negative
|
| 5/31/2016 | BK | Jazz Pharmaceuticals to tap bank loans for $1.5 billion Celator buyout
|
| 7/8/2015 | BKCV | Jazz Pharmaceuticals eyes growth through acquisitions, says CFO
|
| 6/18/2015 | BK | Jazz Pharmaceuticals obtains $1.5 billion five-year credit agreement
|
| 8/7/2014 | BKCV | S&P gives Jazz exchangeables B+
|
| 1/15/2014 | BK | S&P affirms Jazz on upsizing
|
| 12/23/2013 | BK | Jazz Pharmaceuticals $500 million loan expected at Libor plus 275 bps
|
| 12/19/2013 | BK | Jazz Pharmaceuticals plans $500 million term loans for Gentium buy
|
| 6/12/2012 | BK | Market Commentary: Revel term loan falls some more; ResCap better with Berkshire bid; Tank, LHP, WOW set talk
|
| 6/11/2012 | BK | Jazz Pharmaceuticals reduces term loan B size to $475 million
|
| 6/11/2012 | BK | Market Commentary: Jazz Pharmaceuticals, Kronos break; EnergySolutions down with revised guidance, Revel dips
|
| 6/5/2012 | BK | Jazz Pharmaceuticals raises pricing on $600 million credit facility
|
| 6/5/2012 | BK | Market Commentary: Hearthside breaks; Alaska Communications trades up; Jazz, Wastequip, Elo Touch tweak deals
|
| 5/21/2012 | BK | S&P assigns Jazz Pharmaceuticals loan BBB-
|
| 5/16/2012 | BK | Jazz Pharmaceuticals reveals talk on $600 million credit facility
|
| 5/16/2012 | BK | Market Commentary: NGPL, Grohe, Hub break; Momentive up on paydown; Chesapeake slides; Granite reworks deal
|
| 5/14/2012 | BK | Jazz Pharmaceuticals sets Wednesday launch for $600 million facility
|
| 5/14/2012 | BK | Market Commentary: Arch Coal frees up; Bausch & Lomb launches delayed-draw syndication; Jazz reveals timing
|
| 4/27/2012 | BK | Jazz Pharmaceuticals expects to launch $600 million facility in May
|
